Marsha B. Henderson

Marsha B. Henderson is a nationally recognized innovative leader and change agent for the health of women and their families. As the former Associate Commissioner for Women’s Health at the Food and Drug Administration, for a decade, she progressed and managed cutting-edge policy, research and educational outreach initiatives. The Office of Women’s Health advanced its scientific efforts, under her direction, to produce more than 350 research papers and journal articles to facilitate FDA’s regulatory decision-making and promote a better understanding of sex differences and health conditions unique to women. Her tenure produced the first FDA Women’s’ Health Research Roadmap, outlining seven priority areas for new or enhanced research including biomarkers, nanotechnology, cardiovascular disease, and postmarket surveillance as well as a framework to assess its impact. Her colleagues applaud her ability to set a vision and guide the concept to reality. One FDA Commissioner stated, “She is elegant…not just in style but in character, confidence and compassion.”

Ms. Henderson’s expertise in the development of public-private partnerships and culturally appropriate consumer engagement strategies led to the Women’s Health Take Time To Care Program, which has reached over 120 million people with FDA consumer information in 18 languages, and received awards from more than 96 national organizations. Her easy to read, science-based materials have been chronicled in Dear Abby, Parade Magazine, Hints from Heloise, and the IRS, as well as sponsored by external groups including the National Association of Chain Drug Stores, American Diabetes Association, Ford Motor Company, American Medical Association, and even Las Vegas casinos. Her novel efforts supported a one-stop Pregnancy Exposure Registries website to gather information about how prescription drugs or vaccines affect a pregnant woman and her fetus. In addition, she recently instructed her staff to expand the Science of Sex and Gender on-line accredited courses with the NIH/Office of Research on Women’s Health and to conduct FDA’s first “Scientific Conference: Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender” to address this national epidemic.

She is the recipient of numerous awards including the Dr. Estelle Ramey Award for Women’s Health Leadership from Society for Women’s Health Research; “HerMANA” Award for innovative outreach to Hispanic women, and Pinnacle Award for exceptional leadership in medication use for patients and caregivers.  The first non-pharmacist to receive the prestigious Jacob Miller Award from the American Pharmacists Association Foundation, she was also one of five Samuel J. Heyman Service to America Medal (Sammies) finalists from throughout the U.S. federal government. And as Chair of the national board of the YWCA USA, she led the U.S. delegation at the YWCA World Council quadrennial meeting in Bangkok, Thailand to focus on women’s issues.

Prior to her FDA career, Ms. Henderson served as the Director of Evaluation for the Interagency Council on the Homeless; Director of Placement for the National Health Service Corps; Chief of Analysis and Information for the Bureau of Maternal and Child Health; and Senior Advisor to the Director of the Women's Bureau at the U.S. Department of Labor.  Ms. Henderson earned a master’s degree from Rutgers University in health and hospital planning.  She is married to Wade Henderson, an internationally renowned civil and human rights lawyer.

Angie Kalousek Ebrahimi

Angie Kalousek Ebrahimi oversees the sales and marketing of clinically proven lifestyle medicine programs for Blue Shield of California’s members. Angie and her team work to drive both enrollment and engagement in the lifestyle medicine interventions under the Wellvolution brand. Angie strongly believes that lifestyle medicine can transform the current health care model by introducing clinically effective, cost effective and non-invasive lifestyle approaches into the care continuum. She, herself, has incorporated lifestyle medicine into her own life to prevent disease and live in optimal health. Angie is strategically working to forward Blue Shield of California’s philosophy that lifestyle is medicine.

Prior to joining Blue Shield in 2010, Angie worked as the Wellness Program Manager at Visa, Inc. where she created and implemented a new suite of global wellness programs for Visa employees. Part of her role at Visa was to incorporate Visa wellness programming with health plan offerings so that employees had a seamless experience. Prior to her time at Visa, Angie served as the Fitness Director at the Sports Club LA in San Francisco where she oversaw a staff of 60 trainers, nutritionists, and sports coordinators. In her role there, she also managed new member fitness programs, trainer education and direct private training sales. Angie has also worked in marketing, business planning and accounting.

Angie holds an MBA from Golden Gate University, a BS in Business from the University of California, Haas School of Business, Berkeley, and is a Certified Holistic Lifestyle Coach. 

David Portman

Founder, CEO and Medical Director of Sermonix Pharmaceuticals.
Director Emeritus of a Clinical Research Center with research interests in menopause, sexual dysfunction, hormone replacement therapy, SERMs, osteoporosis, contraception and gynecologic endocrinology. Conducted over 140 clinical trials in women’s health.
Lectures nationally, internationally and consults widely on women’s health issues, and is on numerous advisory boards. Board-certified Obstetrician/Gynecologist.

Abel Archundia

Cory Costley

Emilie Wangerman

Emilie brings broad energy industry experience to Lightsource BP. Emilie has over 8 years of experience in power markets and energy policy, on both the buy and sell side of solar, storage, and distributed energy resources (DERs), as well as experience with generation and electric system operations and utility rate design, which is complemented by her background in technology development and process engineering. Prior to Lightsource BP, Emilie worked at Pacific Gas and Electric (“PG&E”), GE Renewable Energy, Corning, and Intel Corporation. Emilie has received a Bachelor of Science in Chemical Engineering and a Bachelor of Science in Psychology from Rensselaer Polytechnic Institute, as well as a Master of Business Administration and a Master of Environmental Management from Duke University. Emilie currently oversees Business Development for the U.S. and started at Lightsource BP in December 2017. Recent transactions Emilie has led include Penn State and SMUD.

Sarah Dye

As Vice President of Oncology and Specialty Pharmaceuticals with Optum’s Medical Benefit Management division, Sarah has responsibility for a comprehensive solution set that includes the Cancer and Specialty Guidance Programs. Sarah is passionate about these complicated conditions and how Optum can help ensure consumers receive quality care and support services to help them navigate a complicated system.

Sarah joined UnitedHealth Group in 2003 and held several other roles including leading Operations and Affordability with Optum International where she focused entirely on the Brazil health care market. Prior to Optum International, Sarah was Principal at UnitedHealth Group Ventures where she analyzed the market to identify new investment opportunities designed to create disruptive, positive change in the health care system.

Across her roles, Sarah uses her engineering training to perform root cause analysis to identify systemic issues in the health care and ultimately design new products to address these issues.  She successfully developed and launched new products in oncology, women’s health and orthopedics.

Sarah holds a bachelor’s degree in industrial engineering from Iowa State University.